A Study of SY-3505 in Patients With Advanced LTK Fusion-Positive Solid Tumors
Status:
RECRUITING
Trial end date:
2026-05-30
Target enrollment:
Participant gender:
Summary
This is an open-label, single-arm, multicenter, phase Ib study to evaluate the efficacy and safety of SY-3505 capsule in patients with locally advanced or metastatic, LTK fusion-positive solid tumor who have progressed on or are intolerant to prior standard therapy.